Scotland · NHS Scotland MSAN
Admelog® (insulin lispro) 100units/ml solution for injection 3ml cartridges
MSAN(2025)43 · Level 2 · issued 22 Sep 2025
What the notice states
The supply position for each affected product, as recorded in the notice — read the full signed PDF above for the clinical advice and actions.
| Product | Position | Resupply |
|---|---|---|
| vials are being discontinued with supplies anticipated to be exhausted by mid-March 2026, late | Discontinued | — |
| remain available and can support increased demand. | Available | — |
| Registration for access to the website is available to UK healthcare professionals and organisations | Available | — |
From the NHS Scotland notice PDF (linked above); dates and “valid until” text are as stated, fuzzy wording kept as written. Scotland is covered separately from England — see methodology. Not an official NHS service, and not clinical advice — follow the guidance issued to your pharmacy.